Eli Lilly & Co. (LLY)
1042.43
-16.13
(-1.52%)
USD |
NYSE |
Feb 24, 16:00
1044.01
+1.58
(+0.15%)
After-Hours: 18:03
Eli Lilly Free Cash Flow : 5.964B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Biogen, Inc. | 1.969B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Viking Therapeutics, Inc. | -278.68M |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.225B |
| Cash from Investing (Quarterly) | -2.802B |
| Cash from Financing (Quarterly) | -2.879B |
| Free Cash Flow Per Share (Quarterly) | 0.2691 |
| Free Cash Flow to Equity (Quarterly) | -1.104B |
| Free Cash Flow to Firm (Quarterly) | 352.96M |
| Free Cash Flow Yield | 0.63% |